Persistence profile to nucleos(t)ide analogue treatment for patients with chronic hepatitis B
{{output}}
Background: There are currently five approved nucleos(t)ide analogues (NUCs) for the management of chronic hepatitis B (CHB): lamivudine, adefovir dipivoxil, telbivudine, entecavir, and tenofovir disoproxil fumarate. ... ...
